Cimetidine

Quick links to important sections

Cimetidine

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cimetidine

Quick Facts

Property Description
Active Ingredient Cimetidine
Form Tablet, Oral Solution, Injection
Pharmacological Class Histamine H2-receptor Antagonist (H2-blocker)
General Purpose Reduction of gastric acid secretion
Origin Synthetic Compound (First-Generation)

What Type of Medicine is Cimetidine?

Cimetidine is a synthetic compound that functions as a systemic antiulcer agent, belonging to the Histamine H2-receptor antagonist (H2-blocker) pharmacological class. Cimetidine is distinguished as the first-generation agent in this class, representing a key milestone in the development of targeted therapies for acid-related conditions. This medicine is a single-ingredient product whose therapeutic effects are derived solely from the Cimetidine active ingredient, possessing the chemical formula C10H16N6S.


What are the Available Forms of Cimetidine?

The active ingredient Cimetidine is prepared in several dosage forms to accommodate various patient needs and administration methods. The medicine is commonly available as a tablet and an oral solution for standard oral administration. Additionally, it is manufactured in sterile preparations for intravenous injection and intramuscular injection, collectively known as parenteral routes. This range of preparation options enables Cimetidine to be utilized in both ambulatory settings and critical care scenarios, such as when a patient cannot take oral medication.


What is the General Purpose of Cimetidine?

The general purpose of Cimetidine is to control and substantially reduce the production of gastric acid in the stomach. It achieves this by acting on the parietal cell H2 receptors, effectively blocking the acid signal that normally stimulates acid secretion. By consistently lowering the acidity within the digestive tract, this medicine helps to relieve the symptoms associated with hyperacidity and promotes a less corrosive environment, which is vital for the natural healing of the digestive lining.

What side effects are possible with Cimetidine?

Possible Side Effects and Safety Information

The safety profile for Cimetidine is classified by regulatory agencies based on incidence and the affected physiological system. Adverse reactions are grouped into categories such as Common, Uncommon, Rare, and Very Rare, aligning with official frequency standards.


Frequency-Classified Adverse Reactions

Classification Examples of Adverse Reactions (by System-Organ Class)
Common Headache, dizziness (Nervous System); Diarrhea (Gastrointestinal); Skin rashes (Dermatological)
Uncommon Confusional states, hallucinations (Psychiatric); Gynecomastia (Reproductive System)
Rare/Very Rare Thrombocytopenia, Agranulocytosis (Blood); Heart block (Cardiac); Interstitial nephritis (Renal)

Documented Serious Adverse Reactions

Rare but serious reactions officially documented include severe hematological effects such as aplastic anaemia and agranulocytosis. There is also documentation of serious cardiac events, like heart block, especially when Cimetidine is administered rapidly by the intravenous route to critically ill patients. Hepatic effects, including fatal hepatic effects, are documented as very rare occurrences.


Population and Exposure-Related Safety Notes

The regulatory safety information notes that older adults and patients with renal impairment have a documented increased susceptibility to confusional states and other central nervous system effects. Furthermore, certain effects are linked to duration; for example, endocrine effects like gynecomastia and reversible impotence are associated with long-term exposure to high doses. In these cases, most documented adverse effects are noted as being reversible upon discontinuation of the medicine.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose occurs when an individual takes more than the normal or recommended amount of cimetidine, either accidentally or intentionally. Though serious complications are rare and overdoses are generally well-tolerated, a rare fatality has been attributed to cimetidine overdose, and seeking medical help is crucial.


Documented Clinical Manifestations

Official regulatory information describes a range of toxic manifestations following an overdose, including central nervous system and cardiovascular effects.

  • Cardiovascular and Respiratory Effects: The most serious reported signs include tachycardia (rapid heart rate) and respiratory depression (dangerously slow or shallow breathing).
  • Other Symptoms: Symptoms generally associated with H2 receptor antagonist overdose may include agitation, confusion, hallucinations, drowsiness, nausea, vomiting, diarrhea, slurred speech, sweating, low blood pressure, and abnormal heartbeat (rapid or slow).

Overdose-related central nervous system effects, such as confusion, agitation, and seizures, have also been reported in susceptible groups, particularly the elderly, the severely ill, and patients with renal failure.


Required Emergency Action

Immediate medical help or contact with a poison control center is required in case of accidental overdose.

If the victim has collapsed, had a seizure, has trouble breathing, or cannot be awakened, immediately call emergency services. The primary emergency response described in labeling involves maintaining the airway and cardiovascular status, providing symptomatic and supportive treatment, and close patient monitoring. Treatment may involve activated charcoal, breathing support, ECG, and intravenous fluids.

Therapeutic Uses of Cimetidine

What Cimetidine Treats: Main Uses and Benefits

Cimetidine is relevant in contexts marked by increased discomfort and is commonly used across conditions presenting with acute episodes and heightened symptoms.

Cimetidine is commonly used to help with conditions involving damage from acid, including active gastric and duodenal ulcers and erosive esophagitis. It is applied in addressing symptom clusters that may become intense or disruptive, such as frequent and uncomfortable heartburn, feelings of sour stomach, and general acid indigestion. It is considered relevant in conditions involving excessive and uncontrolled gastric acid output, such as Zollinger-Ellison syndrome.

The medication is often used when symptoms intensify and supportive relief is needed, contributing to improved comfort during periods of heightened symptoms. It is also applied in specific high-risk clinical scenarios to help manage the risk of complications, such as the formation of stress-related ulcers in critically ill patients, and is commonly used to help with certain symptoms related to inflammatory states, including persistent itching.

“The main therapeutic support provided is focused on easing the symptoms related to acid corrosion and supports patients during episodes of heightened discomfort.”


Quick Fact: Relief for Acid-Related Symptoms

Property Description
Primary Focus Conditions presenting with systemic or localized discomfort.
Symptom Benefit Provides supportive relief when symptoms interfere with routine activities.
Common Scenarios Active ulcer episodes, chronic heartburn, critical care prophylaxis.
Therapeutic Role Supports the patient during difficult episodes by easing distress.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Official Eligibility and Restriction Profile

The use of Cimetidine is governed by official population eligibility rules documented by regulatory authorities. The medicine is absolutely contraindicated in any patient with a known hypersensitivity to the active substance or its excipients.

Age-Related Eligibility

Standard use is generally permitted for adults. For pediatric populations, children 12 years and older are eligible for non-prescription use. However, use in children under 12 requires consulting a doctor, and prescription use in those less than two years of age is not fully established. Older adults are classified as an at-risk group for specific central nervous system effects, particularly when also experiencing severe illness or renal impairment.

Conditional Use and Limitations

Eligibility is conditional for several patient groups. Those with impaired renal function require a reduced dosage as mandated by the label. For patients with gastric ulceration, the regulatory label requires that malignancy must be formally excluded before initiating therapy. Regarding reproductive status, use during pregnancy is restricted to cases of clear need. The medicine is generally not recommended for lactating mothers due to the substance being excreted into human milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Cimetidine is known to interact with a wide range of other medicinal products. The primary mechanism for many of these interactions is the inhibition of several cytochrome P450 (CYP) enzymes in the liver, including CYP1A2, CYP2C9, and CYP3A4. This enzyme inhibition reduces the breakdown of certain co-administered drugs, leading to increased plasma concentrations of those drugs and an elevated risk of side effects or toxicity.

Clinically important interactions include, but are not limited to, those with:

  • Anticoagulants (e.g., warfarin): Increased anticoagulant effect, requiring close monitoring of blood clotting time.
  • Antiarrhythmics (e.g., lidocaine, dofetilide): Increased risk of cardiac toxicity. The co-administration of dofetilide is contraindicated.
  • Anticonvulsants (e.g., phenytoin): Increased plasma levels, requiring monitoring.
  • Xanthines (e.g., theophylline) and certain Beta-blockers (e.g., propranolol, metoprolol): Increased drug levels and potential for toxicity.

Cimetidine also inhibits the renal tubular secretion of certain medicines, such as metformin and procainamide, which also increases their circulating levels. Additionally, as an acid-reducing agent, it raises gastric pH and may decrease the absorption of products that require an acidic environment, such as ketoconazole.

Mechanism of Action

How Cimetidine Works: Mechanism of Action

Cimetidine acts as a competitive antagonist primarily targeting the histamine H2-receptors located on the basolateral membrane of gastric parietal cells. By binding to these receptors, the compound prevents the natural activating ligand, histamine, from initiating the signaling pathway for acid formation. This receptor occupancy serves as the foundational step in the resultant inhibition of acid output.

This H2-receptor blockade effectively interrupts the signal transduction cascade inside the cell that leads to the activation of the H^+/ K^+-ATPase (proton pump). Disruption of this internal cascade results in a reduction in the volume and concentration of hydrogen ions ( H^+) secreted into the stomach lumen.

The physiological consequence of the reduced acid output is a resultant elevation of the intra-gastric pH (decreased acidity). This alteration in the stomach's chemical composition is the direct chemical outcome of the receptor antagonism and the subsequent modulation of the gastric acid secretion process.

Dosage and Administration Information

Cimetidine is administered via two primary routes: the oral route (using tablets or a solution) and the parenteral route (Intravenous (IV) or Intramuscular (IM) injection), with injection forms typically reserved for hospital settings.

Dosing schedules vary based on the prescribed treatment course. For short-term use, regimens include 800 mg taken once daily at bedtime, or doses divided throughout the day, such as 400 mg twice daily or 300 mg four times daily. The maximum dose for pathological hypersecretory conditions is set at 2400 mg per day.

Administration timing is often contextual. The four-times-daily regimen requires doses to be synchronized with meals and at bedtime. For preventative, over-the-counter use, the medicine is taken up to 30 minutes before consuming food or drink that may trigger symptoms. Treatment durations are defined, with short-term courses typically lasting 4 to 8 weeks, and maintenance therapy extending for longer periods.

Specific dosage adjustments are made for certain populations. Patients with marked renal impairment (creatinine clearance less than 30 mL/min) require a reduced frequency, such as 300 mg every 12 hours. Simultaneous intake of Cimetidine and antacids is generally avoided, as this may interfere with the medicine's optimal absorption.

Recent Clinical Evidence

Research evidence / Overview of studies for Cimetidine

Evidence for Healing Active Ulcers

The research examining Cimetidine in conditions characterized by functional limitations, such as active gastric and duodenal ulcers, involves a large body of clinical research. This research includes numerous short-term Randomized Controlled Trials (RCTs). These studies were used in research exploring how symptoms change over time and how to measure ulcer change. The study populations primarily included adult patients with endoscopically confirmed ulcers.

Studies monitored key outcomes related to physical discomfort and tracked objective measurements of ulcer change rates at set intervals. Findings describe patterns observed in the studies regarding the documented changes in ulcer measurements compared to the placebo groups. Research also explored changes in patient-reported outcomes describing perceived discomfort, such as scores for nocturnal and daytime pain. Some trials reported that complete ulcer measurements did not always align with the immediate subjective relief of symptoms reported by the patient.


Studies on Acid Reflux and Esophageal Damage

Clinical trials and RCTs were conducted for conditions characterized by fluctuating or episodic manifestations, such as erosive esophagitis and general heartburn symptoms, where Cimetidine was administered. These trials assessed short-term or episodic symptom patterns and also tracked physical evidence of change in the digestive lining. The study populations were adults presenting with symptoms of acid reflux, including those who had physical erosions confirmed by endoscopy.

Research highlighted changes measured during the study period by evaluating patient-reported outcomes describing perceived discomfort, such as the frequency and severity of heartburn. Studies also monitored the endoscopic change rates of erosive lesions over short-term treatment courses. However, the outcomes regarding complete change may have varied depending on the initial severity of the esophageal damage observed at the start of the study.


Research on Preventing Relapse and Hypersecretory Conditions

For pathologic GI hypersecretory conditions, such as Zollinger-Ellison syndrome, the research base is different due to the rarity of the conditions. Evidence is derived from settings with varying symptom burdens, primarily consisting of Case Series and Clinical Experience Summaries. Research examined changes in gastric acid output and the observed changes in intractable ulcers. The findings describe group patterns, not personal outcomes, and provide insight into short-term changes in these specialized populations.


What Remains Unclear or Requires More Research

The current evidence landscape highlights areas where certainty remains low or where more study is needed. Long-term effects are not fully established regarding the sustained response to Cimetidine beyond the defined follow-up periods of the trials. For some applications, particularly those outside of acid suppression (such as in inflammatory states), the evidence is limited and largely based on small sample sizes or clinical reports. Comparative evidence is lacking in modern research contexts that directly compare Cimetidine to newer or alternative acid-suppressing medications.

Key Studies & References

  1. Cimetidine - StatPearls - NCBI Bookshelf - NIH (Authoritative review of pharmacology and uses)

Frequently Asked Questions (FAQ)

Common questions about Cimetidine (FAQ)


Q: Is Cimetidine available over the counter?

A: Cimetidine is available as a non-prescription (OTC) medication for adults and children 12 years of age and older. According to regulatory documents, the typical over-the-counter tablet strength is 200 mg.


Q: How does Cimetidine differ from other acid reducers like Omeprazole or Famotidine?

A: Official information classifies Cimetidine as a Histamine H2-receptor antagonist, also known as an H2-blocker. This type of medicine works by blocking the signal that tells the stomach to produce acid. Other acid-reducing medications, such as omeprazole, belong to a different chemical class called Proton Pump Inhibitors (PPIs).


Q: What kind of products or foods might interact with Cimetidine?

A: Official product information indicates that no specific food-drug interactions are known to occur with Cimetidine. However, the medicine is known to interact with a wide variety of other prescription medicines and supplements. Regulatory information emphasizes the importance of reviewing all products used with a healthcare professional.


Q: Does Cimetidine affect how birth control pills work?

A: Regulatory safety data reports that Cimetidine can inhibit certain liver enzymes, known as cytochrome P450 enzymes. This mechanism has the potential to affect the way other drugs, including oral contraceptives, are processed in the body.


Q: How long does it typically take for Cimetidine to start working for heartburn?

A: Studies indicate that Cimetidine is rapidly absorbed after an oral dose, with peak concentrations in the blood typically reached within 45 to 90 minutes. Acid secretion inhibition begins quickly, and clinical research has examined patterns of change, noting symptom improvement for many patients after one day of treatment.


Q: If I stop taking Cimetidine, will my symptoms come back right away?

A: Research involving patients with ulcers noted that the sudden discontinuation of Cimetidine resulted in the return of severe symptoms in a number of study subjects. Information regarding the planned discontinuation of the medication is typically reviewed with a healthcare provider.


Q: What happens if I miss a dose of Cimetidine?

A: Official patient information describes protocols for handling a missed dose, typically advising either taking it when remembered or skipping the dose if the next one is near, in order to avoid doubling up. This guidance is in line with official instructions for the medicine's administration.


Q: Does Cimetidine interact with alcohol, and what kind of effect does it have?

A: The official documents do not provide a clear statement on whether alcohol will directly affect Cimetidine itself. However, consuming alcohol is known to potentially exacerbate or worsen certain pre-existing stomach conditions or symptoms.


Q: What should I do if I think I'm having a rare or serious side effect from Cimetidine?

A: In the event a patient experiences a serious adverse effect, official patient safety information instructs that serious adverse effects should be reported to a healthcare provider promptly. Examples of serious effects listed in regulatory documents include confusion, hallucinations, or any unusual signs of bleeding.


Q: Are there any known issues with Cimetidine and blood pressure medication?

A: Regulatory labeling reports that Cimetidine can slow the breakdown of certain blood pressure medications, specifically Beta-blockers and some Calcium Channel Blockers. This change in metabolism may mean that dosage requires monitoring or adjustment by a healthcare provider.


Q: What is the difference between prescription-strength Cimetidine and the OTC version?

A: The primary difference is the dosage strength. The over-the-counter formulation is commonly available as a 200 mg tablet. Prescription-strength versions, used under a doctor's direction, are typically available in higher amounts, such as 400 mg or 800 mg tablets.


Q: Is there a generic version of Cimetidine available?

A: Yes, the active ingredient Cimetidine is widely available as a generic drug. This means it is marketed under its chemical name rather than a specific brand name.


Q: Can Cimetidine cause problems with sleeping or insomnia?

A: While the medicine's label lists common side effects like drowsiness and dizziness, direct reports of insomnia (trouble sleeping) are less common. However, regulatory documents do note reports of confusional states, particularly in certain at-risk populations, which could potentially disrupt normal sleep.


Q: Are people with heart conditions allowed to use Cimetidine?

A: Official safety information notes rare reports of cardiac events, such as a slowed heart rate or heart block, especially when the medicine is administered intravenously in hospital settings. Furthermore, Cimetidine is contraindicated (absolutely forbidden) for use with the antiarrhythmic medicine dofetilide.


Q: What does Cimetidine being a 'histamine H2-receptor antagonist' actually mean in simple terms?

A: In simple terms, this means Cimetidine blocks the action of histamine on certain receptors in the stomach lining. This action prevents the natural chemical signal that would normally tell the stomach cells to start producing acid.


Q: Can Cimetidine be taken at the same time as pain relievers like Ibuprofen or Aspirin?

A: Official information notes that Cimetidine may have an interaction with some common pain relievers known as Nonsteroidal Anti-inflammatory Drugs (NSAIDs), which includes medicines like ibuprofen. The importance of reviewing all pain relievers and other medicines being taken with a healthcare provider is noted in patient information.


Q: How quickly does Cimetidine clear out of the body?

A: According to official pharmacokinetic data, Cimetidine has an elimination half-life of approximately 2 hours in the plasma. This means that after a dose, half of the medicine is cleared from the bloodstream in that time, with the majority of the drug ultimately leaving the body via the urine.


Q: Can Cimetidine cause vitamin B12 deficiency over time?

A: Regulatory and clinical information suggests that because Cimetidine reduces stomach acid, it may interfere with the absorption of Vitamin B12, a process that requires acid. The official drug label does not state a definite risk of developing a clinically significant deficiency from this effect.


Q: Are there different forms of Cimetidine like liquid or chewable tablets?

A: Official documents indicate that Cimetidine is manufactured as both a tablet and an oral solution (liquid) for administration. However, common chewable tablet formulations are not typically listed in the core regulatory product information.


Q: Can Cimetidine be used to help with indigestion not caused by acid reflux?

A: According to the official over-the-counter labeling, the medicine is indicated for relieving heartburn and symptoms associated with acid indigestion and a sour stomach. This limits its defined purpose to conditions directly caused by excess stomach acid.


Q: Does Cimetidine make you feel sleepy or tired during the day?

A: Official safety information lists somnolence (drowsiness) and fatigue as possible side effects. These effects are generally described as mild.


Q: Does Cimetidine have any potential interaction with natural supplements like St. John's Wort?

A: Cimetidine may interact with certain natural supplements, including St. John's Wort. Official patient resources note the importance of reviewing all herbal products and supplements with a healthcare provider.

How should Cimetidine be stored and disposed of?

How to Store and Dispose of Cimetidine

Cimetidine requires storage at controlled room temperature, defined as 20 C to 25 C (68 F to 77 F), with permitted fluctuations between 15 C and 30 C. The oral solution must be specifically protected from freezing.

The medication must be stored in its original container and the container should be kept tightly closed to maintain its integrity. A key regulatory requirement is to keep Cimetidine out of the reach of children for safety.

Disposal of any unused or expired product must be managed according to local and national requirements for pharmaceutical waste, ensuring proper handling and environmental management of the medicine.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cimetidine found in:

A-Z Index: